NCT06267170View on ClinicalTrials.gov

A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

288

Participants

Timeline

Start Date

February 25, 2024

Primary Completion Date

February 25, 2025

Study Completion Date

February 25, 2026

Conditions

SCLC,Extensive Stage

Interventions

DRUG

Adebrelimab

Treatment with adbelizumab

All Listed Sponsors

lead

Henan Cancer Hospital

OTHER_GOV

NCT06267170 - A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter